BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29059342)

  • 1. Mathematical model of calcium exchange during haemodialysis using a citrate containing dialysate.
    Aniort J; Chupin L; Cîndea N
    Math Med Biol; 2018 Mar; 35(suppl_1):87-120. PubMed ID: 29059342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
    Gabutti L; Lucchini B; Marone C; Alberio L; Burnier M
    BMC Nephrol; 2009 Mar; 10():7. PubMed ID: 19265544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation for hemodialysis: calcium-free vs. calcium containing dialysate - a randomized trial.
    Buturovic-Ponikvar J; Cerne S; Gubensek J; Ponikvar R
    Int J Artif Organs; 2008 May; 31(5):418-24. PubMed ID: 18609515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysate made from dry chemicals using citric acid increases dialysis dose.
    Ahmad S; Callan R; Cole JJ; Blagg CR
    Am J Kidney Dis; 2000 Mar; 35(3):493-9. PubMed ID: 10692276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can regional anticoagulation with calcium-free dialysate be extended to maintenance hemodialysis?
    Petitclerc T; Béné B
    Artif Organs; 2024 Jul; 48(7):704-712. PubMed ID: 38716639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dialyzer reuse with citrate dialysate.
    Ahmad S; Callan R; Cole J; Blagg C
    Hemodial Int; 2005 Jul; 9(3):264-7. PubMed ID: 16191076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate haemodialysis.
    Faber LM; de Vries PM; Oe PL; van der Meulen J; Donker AJ
    Neth J Med; 1990 Dec; 37(5-6):219-24. PubMed ID: 2074914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in Inflammation and Calcium Balance of Citrate versus Acetate as Dialysate Buffer in Maintenance Hemodialysis: A Unicentric, Cross-Over, Prospective Study.
    Broseta JJ; López-Romero LC; Cerveró A; Devesa-Such R; Soldevila A; Bea-Granell S; Sánchez-Pérez P; Hernández-Jaras J
    Blood Purif; 2021; 50(6):914-920. PubMed ID: 33535212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate anticoagulation and divalent cations in hemodialysis.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; van der Meulen J
    Blood Purif; 1994; 12(6):308-16. PubMed ID: 7865189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Long-Term Citrate Dialysate Use on Survival in Haemodialysis Patients.
    Séret G; Durand PY; El-Haggan W; Lavainne F; Menanteau M; Testa A; Menoyo V;
    Blood Purif; 2020; 49(6):765-766. PubMed ID: 31494651
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dialysate flow configurations in continuous renal replacement therapy on solute removal: computational modeling.
    Kim JC; Cruz D; Garzotto F; Kaushik M; Teixeria C; Baldwin M; Baldwin I; Nalesso F; Kim JH; Kang E; Kim HC; Ronco C
    Blood Purif; 2013; 35(1-3):106-11. PubMed ID: 23343554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysate pressure isobars in a hollow-fiber dialyzer determined from magnetic resonance imaging and numerical simulation of dialysate flow.
    Osuga T; Obata T; Ikehira H; Tanada S; Sasaki Y; Naito H
    Artif Organs; 1998 Oct; 22(10):907-9. PubMed ID: 9790092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.
    Thijssen S; Kossmann RJ; Kruse A; Kotanko P
    Blood Purif; 2013; 35(1-3):133-8. PubMed ID: 23343558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mathematical model of regional citrate anticoagulation in hemodialysis.
    Thijssen S; Kruse A; Raimann J; Bhalani V; Levin NW; Kotanko P
    Blood Purif; 2010; 29(2):197-203. PubMed ID: 20093827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated regional citrate anticoagulation: technological barriers and possible solutions.
    Szamosfalvi B; Frinak S; Yee J
    Blood Purif; 2010; 29(2):204-9. PubMed ID: 20093828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A; El Kabbaj D; Benyahia M; Asseraji M; Zemraoui N
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium.
    Gonzalez-Parra E; Gonzalez-Casaus ML; Arenas MD; Sainz-Prestel V; Gonzalez-Espinoza L; Muñoz-Rodriguez MA; Tabikh A; Egido J; Ortiz A
    Blood Purif; 2014; 38(3-4):224-33. PubMed ID: 25531119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysate calcium loss using a calcium free dialysate.
    Kaye M
    Int J Artif Organs; 1994 Jul; 17(7):365-72. PubMed ID: 7806422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.